Elevated serum CA-125 concentrations due to expression by a diffuse large B-cell lymphoma.
Vlasveld
L T
LT
Department of Internal Medicine, Diaconessenhuis, Eindhoven, The Netherlands.
Ermens
A A
AA
Sonnenberg
A A
AA
Pauwels
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008207:Lymphatic Metastasis; D016393:Lymphoma, B-Cell / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D007770:L-Lactate Dehydrogenase